U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C5H7NO4.Mg.2H.4H2O
Molecular Weight 388.6088
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MAGNESIUM L-GLUTAMATE TETRAHYDRATE

SMILES

[H+].[H+].O.O.O.O.[Mg++].N[C@@H](CCC([O-])=O)C([O-])=O.N[C@@H](CCC([O-])=O)C([O-])=O

InChI

InChIKey=ZWCGDRSVJYJGFY-GYDBBPQESA-L
InChI=1S/2C5H9NO4.Mg.4H2O/c2*6-3(5(9)10)1-2-4(7)8;;;;;/h2*3H,1-2,6H2,(H,7,8)(H,9,10);;4*1H2/q;;+2;;;;/p-2/t2*3-;;;;;/m00...../s1

HIDE SMILES / InChI
Magnesium glutamate hydrobromide (Psychoverlan) is a known sedative and muscle relaxant. In a long-term study 19 young females were treated with Psychoverlan capsules or syrup for an average of 11.4 months. Intolerance phenomena and side-effects were not seen. It was even decided to increase the standard dose. None of the patients developed brominism or bromine intoxication. The general state of health of 13 of the 19 subjects was improved by the harmonizing effect of the drug on psychic and vegetative functions. Tiredness and somnolence were not observed.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
PSYCHOVERLAN

Approved Use

Nervous system disorders
PubMed

PubMed

TitleDatePubMed
Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs.
2015-01-15
No enhancing effects of calcium/magnesium salts of L-glutamate and L-ascorbate on tumor development in a rat medium-term multiorgan carcinogenesis bioassay.
1993-05
[Long-term treatment with psychoverlan in children and adolescents with behavior disorders].
1978-08-24
[The management of nervous disturbances with psychoverlan].
1974-05
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Rats were given diet containing 5% monocalcium di-L-glutamate tetrahydrate (Ca-glutamate), 2.5% monomagnesium di-L-glutamate tetrahydrate (Mg-glutamate), 5% L-glutamic acid, 5% monocalcium di-L-ascorbate dihydrate (Ca-ascorbate), 2.5% monomagnesium di-L-ascorbate dihydrate (Mg-ascorbate), or 5% L-ascorbic acid for 16 wk.
Unknown
Route of Administration: Oral
60 g (0.160 mol) magnesium-L-glutamate-tetrahydrate in a spherical flask were suhmerged in the rotary evaporator under a vacuum of 50 mbar in an oil bath that had been preheated to 190C. The separation of water and the formation of the magnesium-L-pyroglutamate began after 2 minutes and ended after 45 minutes, a solid being involved at each stage of the reaction.
Name Type Language
L-GLUTAMIC ACID, MAGNESIUM SALT (2:1), TETRAHYDRATE
Preferred Name English
MAGNESIUM L-GLUTAMATE TETRAHYDRATE
Systematic Name English
MAGNESATE(2-), BIS(L-GLUTAMATO(2-)-N,O1)-, DIHYDROGEN, TETRAHYDRATE, (T-4)-
Systematic Name English
MAGNESIUM DI-L-GLUTAMATE
Systematic Name English
Code System Code Type Description
CODEX ALIMENTARIUS (GSFA)
INS-626
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY
CAS
129160-51-6
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY
FDA UNII
S8TL3KXK0I
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY
PUBCHEM
71311557
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY
JECFA EVALUATION
INS-625
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY
EVMPD
SUB68830
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY
SMS_ID
100000134894
Created by admin on Mon Mar 31 23:05:22 GMT 2025 , Edited by admin on Mon Mar 31 23:05:22 GMT 2025
PRIMARY